Pedro A Lemos
Overview
Explore the profile of Pedro A Lemos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
248
Citations
2629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernardi F, Abizaid A, de Brito Jr F, Lemos P, Siqueira D, Costa R, et al.
Arq Bras Cardiol
. 2024 Jul;
121(7):e20230622.
PMID: 39082574
Background: Robust data on the learning curve (LC) of transcatheter aortic valve replacement (TAVR) are lacking in developing countries. Objective: To assess TAVR's LC in Brazil over time. Methods: We...
2.
Wang H, Zhou T, Ma W, Zheng J, Cao Z, He C, et al.
J Thorac Dis
. 2024 May;
16(4):2443-2459.
PMID: 38738236
Background: Myocardial infarction (MI) is one of the most lethal cardiovascular diseases. The loss of cardiomyocytes and the degradation of the extracellular matrix leads to high ventricular wall stress, which...
3.
Scarpa Matuck B, Akino N, Bakhshi H, Cox C, Ebrahimihoor E, Ishida M, et al.
J Cardiovasc Comput Tomogr
. 2024 May;
18(5):444-449.
PMID: 38702271
Background: Direct coronary arterial evaluation via computed tomography (CT) angiography is the most accurate noninvasive test for the diagnosis of coronary artery disease (CAD). However, diagnostic accuracy is limited in...
4.
Araujo G, Machado G, Moura M, Silveira A, Bergoli L, Costa Fuchs F, et al.
Cardiovasc Revasc Med
. 2024 Mar;
65:52-57.
PMID: 38492976
Background: Coronary drug-eluting stents (DES) built with either durable (DP) or biodegradable (BP) polymeric coatings have been largely tested and are extensively available for routine use. However, their comparative performance...
5.
Masuda S, Tanabe K, Guimaraes P, Muramatsu T, Ozaki Y, Martino F, et al.
JACC Asia
. 2024 Mar;
4(3):171-182.
PMID: 38463674
Background: The ASET (Acetyl-Salicylic Elimination Trial) pilot studies recently investigated P2Y inhibitor monotherapy without aspirin immediately after percutaneous coronary intervention (PCI) in Brazil and Japan. Objectives: This comparative analysis of...
6.
Kotoku N, Ninomiya K, Masuda S, Tsai T, Revaiah P, Garg S, et al.
Int J Cardiol
. 2024 Jan;
400:131805.
PMID: 38272132
Background: The geographical disparity in the pathophysiological pattern of coronary artery disease (CAD) among patients undergoing percutaneous coronary intervention (PCI) is unknown. Objectives: To elucidate the geographical variance in the...
7.
Bulant C, Boroni G, Bass R, Raber L, Lemos P, Garcia-Garcia H, et al.
Sci Rep
. 2024 Jan;
14(1):1493.
PMID: 38233429
Coronary artery disease is defined by the existence of atherosclerotic plaque on the arterial wall, which can cause blood flow impairment, or plaque rupture, and ultimately lead to myocardial ischemia....
8.
Abdelshafy M, Serruys P, Tsai T, Revaiah P, Garg S, Aben J, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1161779.
PMID: 37529710
Paravalvular leak (PVL) is a shortcoming that can erode the clinical benefits of transcatheter valve replacement (TAVR) and therefore a readily applicable method (aortography) to quantitate PVL objectively and accurately...
9.
Prado G, Garzon S, Mariani J, Caixeta A, O Almeida B, O Ramalho F, et al.
Ren Fail
. 2023 Jun;
45(1):2224888.
PMID: 37350345
Background: Candidates for transcatheter aortic valve implantation (TAVI) are currently evaluated using computed tomography angiography and invasive cardiac catheterization as an essential part of case selection and pre-procedure interventional planning....
10.
Garzon S, Lemos P
Arq Bras Cardiol
. 2023 Jun;
120(5):e20230283.
PMID: 37341250
No abstract available.